Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Gliosarcoma 6Glioblastoma 6Brain Neoplasms 5Glioma 2Central Nervous System Neoplasms 2Oligodendroglioma 1Meningioma 1Fibroma 1Ependymoma 1Desmoid Tumors 1Astrocytoma 1

Interventions

seclidemstat 1Topotecan 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Imatinib Mesylate 1Hydroxyurea 1Cyclophosphamide 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibroma × Hydroxyurea × Sarcoma × Clear all
NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn
Sarcoma

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡